Celyad Oncology SA, a Belgian cell therapy developer, has made a private share placement with an affiliate of the Fortress Investment Group, raising $32.5 million to help support its operations into the first half of 2023. The placement involved 6.5 million ordinary shares and was arranged by SVB Leerink.
